This inventor holds 1 USPTO granted patent. Top assignee: Pharmagenesis, Inc.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Tien-Wen Tao Wiedmann: Innovator in Immunotherapy
Introduction
Tien-Wen Tao Wiedmann is a notable inventor based in Redwood City, CA (US). She has made significant contributions to the field of immunotherapy, particularly in the development of compositions and methods for immunosuppression therapy. Her innovative work has the potential to impact the treatment of transplantation rejection.
Latest Patents
Wiedmann holds a patent for an immunotherapy composition and method. The patent describes a composition that includes an immunosuppressant drug, such as cyclosporin A, combined with an ethanol extract of the root xylem of Tripterygium wilfordii. This extract is effective on its own or in combination with the immunosuppressant in treating transplantation rejection. The method of immunosuppression involves administering a pharmaceutically effective amount of both the immunosuppressant drug and the extract to enhance the drug's action.
Career Highlights
Wiedmann is associated with Pharmagenesis, Inc., where she continues to advance her research in immunotherapy. Her work is characterized by a commitment to improving therapeutic outcomes for patients undergoing transplantation.
Collaborations
Wiedmann collaborates with esteemed colleagues, including Jian Wang and Nathan B Pliam, who contribute to her research endeavors.
Conclusion
Tien-Wen Tao Wiedmann's innovative work in immunotherapy showcases her dedication to enhancing medical treatments for transplantation rejection. Her contributions are paving the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile